Horizon Discovery Group (HZD)
18/12/2017 - 08:20 StockMarketWire
orizon Discovery Grouhas entered into an agreement with Roche Diagnostics to assist in the development of immunohisto...
18/12/2017 - 07:00 RNS
RNS Number: 5776Z Horizon Discovery Group plc 18 December 2017 Horizon Discovery enters into agreement with Roche Diagnostics to support the development of immunohistochemistry assays for oncology Horizon to develop and manufacture FFPE Reference Standards that express NTRK fusion biomarkers Standards to be derived from custom gene edited cel...
05/12/2017 - 07:58 StockMarketWire
Horizon Discovery Group and ERS Genomics have announced the extension of their pre-existing non-exclusive, worldwide...
05/12/2017 - 07:00 RNS
RNS Number: 3618Y Horizon Discovery Group plc 05 December 2017 Horizon extends industry-leading gene editing IP portfolio through expansion of CRISPR license rights with ERS Genomics Breadth of research use rights now expanded to include multiple new species Grant of rights to have products made and sold by partners Grant of sub-licensed rights to one s...
Join interactive investor
- £22.50 fixed quarterly charge includes £22.50 in trading credits
- £10 per trade or £6 for frequent traders
- No % platform fees
- £1 per trade for regular investment or dividend reinvestment